CRH Revises Full-Year EBITDA Guidance
CRH has revised its full-year EBITDA guidance, now projecting a range of $7.5 billion to $7.7 billion, a tighter estimate compared to the previous $7.3 billion to $7.7 billion. Analysts had anticipated an adjusted EBITDA of approximately $7.47 billion.
Financial Outlook and Performance
The company's capital expenditure forecast remains steady between $2.8 billion and $3.0 billion. In the first half, sales reached $16.96 billion, marginally below the expected $17.27 billion. The first-half adjusted EBITDA was $2.96 billion, translating to a 17.4% margin. For the second quarter, net income stood at $1.3 billion, while adjusted EBITDA hit $2.5 billion.
Drivers of Second-Quarter Results
These robust second-quarter results were driven by strong demand fundamentals, strategic commercial management, and acquisitions. Market analysts currently rate CRH with 21 buy recommendations, five holds, and a single sell.
Analyst Perspectives and Market Sentiment
On Smartkarma, analyst Travis Lundy highlights a bullish outlook for CRH, discussing upcoming index rebalancing activities and potential opportunities...